IBDEI06K ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2875,1,3,0)
 ;;=3^SCRN MAL NEOP PROSTATE
 ;;^UTILITY(U,$J,358.3,2875,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,2875,2)
 ;;=^321548
 ;;^UTILITY(U,$J,358.3,2876,0)
 ;;=V76.45^^28^249^79
 ;;^UTILITY(U,$J,358.3,2876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2876,1,3,0)
 ;;=3^SCRN MAL NEOP TESTIS
 ;;^UTILITY(U,$J,358.3,2876,1,4,0)
 ;;=4^V76.45
 ;;^UTILITY(U,$J,358.3,2876,2)
 ;;=^321549
 ;;^UTILITY(U,$J,358.3,2877,0)
 ;;=V76.46^^28^249^74
 ;;^UTILITY(U,$J,358.3,2877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2877,1,3,0)
 ;;=3^SCRN MAL NEOP OVARY
 ;;^UTILITY(U,$J,358.3,2877,1,4,0)
 ;;=4^V76.46
 ;;^UTILITY(U,$J,358.3,2877,2)
 ;;=^322084
 ;;^UTILITY(U,$J,358.3,2878,0)
 ;;=V76.47^^28^249^80
 ;;^UTILITY(U,$J,358.3,2878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2878,1,3,0)
 ;;=3^SCRN MAL NEOP VAGINA
 ;;^UTILITY(U,$J,358.3,2878,1,4,0)
 ;;=4^V76.47
 ;;^UTILITY(U,$J,358.3,2878,2)
 ;;=^322085
 ;;^UTILITY(U,$J,358.3,2879,0)
 ;;=V76.51^^28^249^69
 ;;^UTILITY(U,$J,358.3,2879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2879,1,3,0)
 ;;=3^SCRN MAL NEOP INTESTINE
 ;;^UTILITY(U,$J,358.3,2879,1,4,0)
 ;;=4^V76.51
 ;;^UTILITY(U,$J,358.3,2879,2)
 ;;=^322089
 ;;^UTILITY(U,$J,358.3,2880,0)
 ;;=V76.81^^28^249^72
 ;;^UTILITY(U,$J,358.3,2880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2880,1,3,0)
 ;;=3^SCRN MAL NEOP NERVOUS SYSTEM
 ;;^UTILITY(U,$J,358.3,2880,1,4,0)
 ;;=4^V76.81
 ;;^UTILITY(U,$J,358.3,2880,2)
 ;;=^322091
 ;;^UTILITY(U,$J,358.3,2881,0)
 ;;=V77.0^^28^249^59
 ;;^UTILITY(U,$J,358.3,2881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2881,1,3,0)
 ;;=3^SCREEN-THYROID DISORDER
 ;;^UTILITY(U,$J,358.3,2881,1,4,0)
 ;;=4^V77.0
 ;;^UTILITY(U,$J,358.3,2881,2)
 ;;=^295661
 ;;^UTILITY(U,$J,358.3,2882,0)
 ;;=V77.1^^28^249^18
 ;;^UTILITY(U,$J,358.3,2882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2882,1,3,0)
 ;;=3^SCREEN-DIABETES MELLITUS
 ;;^UTILITY(U,$J,358.3,2882,1,4,0)
 ;;=4^V77.1
 ;;^UTILITY(U,$J,358.3,2882,2)
 ;;=^295662
 ;;^UTILITY(U,$J,358.3,2883,0)
 ;;=V77.2^^28^249^40
 ;;^UTILITY(U,$J,358.3,2883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2883,1,3,0)
 ;;=3^SCREEN-MALNUTRITION
 ;;^UTILITY(U,$J,358.3,2883,1,4,0)
 ;;=4^V77.2
 ;;^UTILITY(U,$J,358.3,2883,2)
 ;;=^295663
 ;;^UTILITY(U,$J,358.3,2884,0)
 ;;=V77.3^^28^249^49
 ;;^UTILITY(U,$J,358.3,2884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2884,1,3,0)
 ;;=3^SCREEN-PHENYLKETONURIA
 ;;^UTILITY(U,$J,358.3,2884,1,4,0)
 ;;=4^V77.3
 ;;^UTILITY(U,$J,358.3,2884,2)
 ;;=^295664
 ;;^UTILITY(U,$J,358.3,2885,0)
 ;;=V77.4^^28^249^23
 ;;^UTILITY(U,$J,358.3,2885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2885,1,3,0)
 ;;=3^SCREEN-GALACTOSEMIA
 ;;^UTILITY(U,$J,358.3,2885,1,4,0)
 ;;=4^V77.4
 ;;^UTILITY(U,$J,358.3,2885,2)
 ;;=^295665
 ;;^UTILITY(U,$J,358.3,2886,0)
 ;;=V77.5^^28^249^27
 ;;^UTILITY(U,$J,358.3,2886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2886,1,3,0)
 ;;=3^SCREEN-GOUT
 ;;^UTILITY(U,$J,358.3,2886,1,4,0)
 ;;=4^V77.5
 ;;^UTILITY(U,$J,358.3,2886,2)
 ;;=^295666
 ;;^UTILITY(U,$J,358.3,2887,0)
 ;;=V77.6^^28^249^15
 ;;^UTILITY(U,$J,358.3,2887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2887,1,3,0)
 ;;=3^SCREEN-CYSTIC FIBROSIS
 ;;^UTILITY(U,$J,358.3,2887,1,4,0)
 ;;=4^V77.6
 ;;^UTILITY(U,$J,358.3,2887,2)
 ;;=^295667
 ;;^UTILITY(U,$J,358.3,2888,0)
 ;;=V77.7^^28^249^33
 ;;^UTILITY(U,$J,358.3,2888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2888,1,3,0)
 ;;=3^SCREEN-INBORN ERR METAB
 ;;^UTILITY(U,$J,358.3,2888,1,4,0)
 ;;=4^V77.7
 ;;^UTILITY(U,$J,358.3,2888,2)
 ;;=^295668
 ;;^UTILITY(U,$J,358.3,2889,0)
 ;;=V77.8^^28^249^46
